Costechareyre Denis, Capo Florence, Fabre Alexandre, Chaduli Delphine, Kellenberger Christine, Roussel Alain, Charroux Bernard, Royet Julien
Institut de Biologie du Dx00E9;veloppement de Marseille, UMR 7288, CNRS, Aix Marseille Universitx00E9;, Marseille, France.
J Innate Immun. 2016;8(1):67-80. doi: 10.1159/000437368. Epub 2015 Oct 30.
In Drosophila, peptidoglycan (PGN) is detected by PGN recognition proteins (PGRPs) that act as pattern recognition receptors. Some PGRPs such as PGRP-LB or PGRP-SCs are able to cleave PGN, therefore reducing the amount of immune elicitors and dampening immune deficiency (IMD) pathway activation. The precise role of PGRP-SC is less well defined because the PGRP-SC genes (PGRP-SC1a, PGRP-SC1b and PGRP-SC2) lie very close on the chromosome and have been studied using a deletion encompassing the three genes. By generating PGRP-SC-specific mutants, we reevaluated the roles of PGRP-LB, PGRP-SC1 and PGRP-SC2, respectively, during immune responses. We showed that these genes are expressed in different gut domains and that they follow distinct transcriptional regulation. Loss-of-function mutant analysis indicates that PGRP-LB is playing a major role in IMD pathway activation and bacterial load regulation in the gut, although PGRP-SCs are expressed at high levels in this organ. We also demonstrated that PGRP-SC2 is the main negative regulator of IMD pathway activation in the fat body. Accordingly, we showed that mutants for either PGRP-LB or PGRP-SC2 displayed a distinct susceptibility to bacteria depending on the infection route. Lastly, we demonstrated that PGRP-SC1 and PGRP-SC2 are required in vivo for full Toll pathway activation by Gram-positive bacteria.
在果蝇中,肽聚糖(PGN)由作为模式识别受体的肽聚糖识别蛋白(PGRPs)检测。一些PGRPs,如PGRP-LB或PGRP-SCs能够切割PGN,从而减少免疫激发子的数量并抑制免疫缺陷(IMD)途径的激活。PGRP-SC的确切作用尚不太明确,因为PGRP-SC基因(PGRP-SC1a、PGRP-SC1b和PGRP-SC2)在染色体上位置非常接近,并且一直是通过包含这三个基因的缺失来进行研究的。通过构建PGRP-SC特异性突变体,我们分别重新评估了PGRP-LB、PGRP-SC1和PGRP-SC2在免疫反应中的作用。我们发现这些基因在不同的肠道区域表达,并且遵循不同的转录调控。功能缺失突变体分析表明,尽管PGRP-SCs在该器官中高水平表达,但PGRP-LB在肠道的IMD途径激活和细菌载量调节中起主要作用。我们还证明,PGRP-SC2是脂肪体中IMD途径激活的主要负调节因子。因此,我们表明,PGRP-LB或PGRP-SC2的突变体根据感染途径对细菌表现出不同的易感性。最后,我们证明PGRP-SC1和PGRP-SC2在体内是革兰氏阳性菌完全激活Toll途径所必需的。